LIU Hua, MA Haijian, GONG Hongchao. Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 118-121. DOI: 10.7619/jcmp.202017032
Citation: LIU Hua, MA Haijian, GONG Hongchao. Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 118-121. DOI: 10.7619/jcmp.202017032

Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment

More Information
  • Received Date: May 25, 2020
  • Available Online: September 29, 2020
  • Objective To observe effect of risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment. Methods A total of 22 pregnant women with late threatened abortion by treatment of magnesium sulfate from January to December 2019 were selected as observation group, and they were conducted with whole process risk warning management. Another 25 pregnant women without risk warning management before 2019 were selected as control group. The mastery degree of risk warning management indicators(score for mastery of drug knowledge, score for standard manipulations of magnesium sulfate and infusion pump, score for quality control inspection of high-risk drug management)of nurses in charge of pregnant women in both groups were compared. The satisfaction degree of pregnant women to nursing services, scores of Self-rating Anxiety Scale(SAS)and Self-rating Depression Scale(SDS), and nursing risk events were compared between the two groups. Results Score for mastery of drug knowledge, score for standard manipulations of magnesium sulfate and infusion pump, and score for quality control inspection of high-risk drug management of nurses in charge of pregnant women in the observation group were significantly higher than those in the control group(P<0.05). The satisfaction degree of pregnant women in the observation group was 90.91%(20/22), which was significantly higher than 64.00%(16/25)in the control group(P<0.05). The scores of SAS and SDS in the observation group were significantly lower than those in the control group(P<0.05). The incidence of nursing risk events in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Risk warning management can effectively reduce the incidence of nursing risk events, enhance the risk awareness and prevention ability of nursing staffs, increase the satisfaction degree of pregnant women, and ensure safety of pregnant women.
  • 叶小丽, 吴志军, 许园姣. 不同宫缩抑制剂在先兆早产治疗中临床疗效与安全性的研究[J]. 中国妇幼健康研究, 2017, 28(8): 957-960.
    马燕, 陈丹青. 早产药物治疗的循证评价[J]. 实用妇产科杂志, 2019, 35(7): 489-491.
    刘爱莲. 盐酸利托君与硫酸镁治疗早产临床效果与安全性研究[J]. 世界最新医学信息文摘, 2019, 19(73): 134-135.
    马腾, 周莉. 硫酸镁对早产儿脑神经保护作用的研究进展[J]. 中国医刊, 2020, 55(2): 130-133.
    金晶, 邹丽. 硫酸镁对胎儿及新生儿的影响[J]. 妇产与遗传: 电子版, 2014, 4(1): 45-48.
    HANLEY M, SAYRES L, REIFF E S, et al, Tocolysis: a review of the literature[J]. Obstet Gynecol Surv, 2019, 74(1): 50-55.
    DOYLE LW, CROWTHER CA, MIDDLETON P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus[J]. Cochrane Database Syst Rev, 2009(1): CD004661.
    刘洋铭, 王寒冰, 漆洪波. 美国妇产科医师学会早产管理指南2016年补充公告解读[J]. 中国实用妇科与产科杂志, 2016, 32(12): 1189-1192.
    韩雪玲, 杜晓琴. 硫酸镁对有早产风险孕妇胎儿神经保护的研究进展[J]. 继续医学教育, 2017, 31(6): 144-146.
    殷祝美. 盐酸利托君与硫酸镁治疗早产临床效果与安全性分析[J]. 临床合理用药杂志, 2017, 10(23): 61-62.

Catalog

    Article views (358) PDF downloads (14) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return